Učitavanje...

The Potential of Computational Modeling to Predict Disease Course and Treatment Response in Patients with Relapsing Multiple Sclerosis

As of today, 20 disease-modifying drugs (DMDs) have been approved for the treatment of relapsing multiple sclerosis (MS) and, based on their efficacy, they can be grouped into moderate-efficacy DMDs and high-efficacy DMDs. The choice of the drug mostly relies on the judgment and experience of neurol...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cells
Glavni autori: Pappalardo, Francesco, Russo, Giulia, Pennisi, Marzio, Parasiliti Palumbo, Giuseppe Alessandro, Sgroi, Giuseppe, Motta, Santo, Maimone, Davide
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7140535/
https://ncbi.nlm.nih.gov/pubmed/32121606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9030586
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!